FDA Approval Controversy
A small study on a new ALS drug showed promising results, but skepticism from an advisory committee initially halted its approval. However, a passionate outcry from patients and their families led to a rare reconsideration, ultimately resulting in a 7-2 vote in favor of approval. The emotional plea for access to potentially life-saving treatment highlights the desperate circumstances faced by those with terminal illnesses.In this clip
From this podcast
Short Wave
A New Drug For A Relentless Brain Disease
Related Questions